Please enable JS

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness

Publication ID: 
GBI0718001
Publication Date: 
July 01, 2018
Pages: 
138
Publisher: 
GBI Research
Region: 
$4,995.00
Please choose the suitable license type from above. More details are at given under tab "Report License Types" below.
Custom Market Research Reports
Need Custom Market Research Solution?

Want to commission a custom market research to suit your needs? We are here to help. Let us know.